MARX Biotech Co (ROCO:7731) Payments of Debt: NT$-127.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
18 GF Score
Price NT$4.18
! 5 Warning Signs
View Full Analysis

What is MARX Biotech Co Payments of Debt?

MARX Biotech Co ROCO:7731 +0.71% 18 Payments of Debt is NT$-127.0 Mil as of Jun. 2026. GuruFocus rates ROCO:7731 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

MARX Biotech Co's Payments of Debt for the six months ended in Jun. 2026 was NT$-88.7 Mil.

MARX Biotech Co's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-127.0 Mil.

MARX Biotech Co Payments of Debt Related Terms

MARX Biotech Co Payments of Debt Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Payments of Debt Chart

MARX Biotech Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
-0.50 0.00 -25.99 170.31 -13.17

MARX Biotech Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Payments of Debt Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -23.94 -38.31 -88.66
ROCO:7731
18GF Score
MARX Biotech Co Ltd ROCO:7731
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-127.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of NT$-127.0 Mil mean?
MARX Biotech Co (ROCO:7731) has a Payments of Debt of NT$-127.0 Mil as of Jun. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's Payments of Debt too high?
MARX Biotech Co's current Payments of Debt is NT$-127.0 Mil. Overall, MARX Biotech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Payments of Debt compare to competitors?
MARX Biotech Co's Payments of Debt of NT$-127.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Healthcare Providers & Services company?
A good Payments of Debt depends on the Healthcare Providers & Services industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current Payments of Debt is NT$-127.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Payments of Debt of NT$-127.0 Mil. The current Payments of Debt is NT$-127.0 Mil. MARX Biotech Co's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Payments of Debt is NT$-127.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a Taiwan-based company engaged in the retail and distribution of cosmeceutical and personal care products. It operates an online-to-offline and online-merge-offline channel model that combines e-commerce platforms with physical retail outlets. The company distributes its products through a network of pharmacies and drugstores across Taiwan, including chains such as Cosmed, Watsons, Dashu Pharmacy, Dingding Pharmacy, and Spring Pharmacy, as well as independent pharmacies. Its product range covers skincare, beauty, and health-related consumer goods positioned at the intersection of cosmetics and pharmaceuticals. Revenue is generated primarily through product sales via these retail channels and its own online platforms. By integrating digital and physical retail, MARX Biotech serves Taiwanese consumers seeking accessible cosmeceutical products through both online ordering and in-store purchasing.
18GF Score

Get the complete analysis for ROCO:7731

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.18
Price